Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus

Abstract

Objective:

Patent ductus arteriosus (PDA) is common in preterm infants and is associated with significant morbidities. B type natriuretic peptide (BNP) is synthesized in the ventricles secondary to volume overload and excreted as urinary N-terminal pro-brain natriuretic peptide (NT-proBNP).

Study Design:

We report an observational prospective study of 64 preterm infants with birth weight 1000 g. Echocardiographic parameters were obtained from clinical echocardiograms performed in the first week of life. Urinary NT-proBNP/creatinine ratios (pg mg−1) were measured on the same day of the echocardiograms.

Results:

Infants with medium to large PDA (n=39) had significantly higher NT-proBNP/creatinine levels compared with infants with small PDA (n=10) (median (IQ range): 2333 (792–6166) vs 714 (271–1632) pg mg−1, P=0.01) and compared with infants with no PDA (n=15) (2333 (792–6166) vs 390 (134–1085) pg mg−1, P=0.0003). Urinary NT-proBNP/creatinine ratios were significantly lower post treatment if PDA closed (n=17), P=0.001 or if PDA became smaller after treatment (n=9), P=0.004. Urinary NT-proBNP/creatinine levels correlated with ductal diameter (P0.0001), but not with LA/Ao ratio (P=0.69) or blood flow velocity through the ductus (P=0.06).

Conclusion:

Our findings indicate that there is a positive correlation between ductal diameter and urinary NT-proBNP in preterm infants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR . The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000; 106 (4): 659–671.

    Article  CAS  Google Scholar 

  2. Kluckow M, Evans N . Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137 (1): 68–72.

    Article  CAS  Google Scholar 

  3. Todd DA, Jana A, John E . Chronic oxygen dependency in infants born at 24-32 weeks' gestation: the role of antenatal and neonatal factors. J Paediatr Child Health 1997; 33 (5): 402–407.

    Article  CAS  Google Scholar 

  4. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM . Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999; 104 (6): 1345–1350.

    Article  CAS  Google Scholar 

  5. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989; 320 (23): 1511–1516.

    Article  CAS  Google Scholar 

  6. John E, Todd DA . Patent ductus arteriosus and retinopathy of prematurity in infants below 27 weeks gestation. Aust Paediatr J 1988; 24 (3): 171–173.

    CAS  PubMed  Google Scholar 

  7. Kwinta P, Rudzinski A, Kruczek P, Kordon Z, Pietrzyk JJ . Can early echocardiographic findings predict patent ductus arteriosus? Neonatology 2009; 95 (2): 141–148.

    Article  Google Scholar 

  8. Kluckow M, Seri I, Evans N . Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr 2007; 150 (2): 125–130.

    Article  Google Scholar 

  9. Chiruvolu A, Jaleel MA . Pathophysiology of patent ductus arteriosus in premature neonates. Early Hum Dev 2009; 85 (3): 143–146.

    Article  CAS  Google Scholar 

  10. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR . Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117 (4): 1113–1121.

    Article  Google Scholar 

  11. Hobbs FD, Jones MI, Allan TF, Wilson S, Tobias R . European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J 2000; 21 (22): 1877–1887.

    Article  CAS  Google Scholar 

  12. Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993; 88 (2): 372–380.

    Article  CAS  Google Scholar 

  13. Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD . N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2008; 93 (4): F257–F260.

    Article  CAS  Google Scholar 

  14. Gobinet-Georges A, Valli N, Filliatre H, Dubernet MF, Dedeystere O, Bordenave L . Stability of brain natriuretic peptide (BNP) in human whole blood and plasma. Clin Chem Lab Med 2000; 38 (6): 519–523.

    Article  CAS  Google Scholar 

  15. Shimizu H, Aono K, Masuta K, Asada H, Misaki A, Teraoka H . Stability of brain natriuretic peptide (BNP) in human blood samples. Clin Chim Acta 1999; 285 (1–2): 169–172.

    Article  CAS  Google Scholar 

  16. Kemperman H, van den Berg M, Kirkels H, de Jonge N . B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 2004; 50 (9): 1670–1672.

    Article  CAS  Google Scholar 

  17. Tosse V, Pillekamp F, Verde P, Hadzik B, Sabir H, Mayatepek E et al. Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants. Neonatology 2012; 101 (4): 260–266.

    Article  CAS  Google Scholar 

  18. Letzner J, Berger F, Schwabe S, Benzing J, Morgenthaler NG, Bucher HU et al. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Neonatology 2012; 101 (2): 116–124.

    Article  CAS  Google Scholar 

  19. Ramakrishnan S, Heung YM, Round J, Morris TP, Collinson P, Williams AF . Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr 2009; 98 (8): 1254–1259.

    Article  CAS  Google Scholar 

  20. Nuntnarumit P, Khositseth A, Thanomsingh P . N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. J Perinatol 2009; 29 (2): 137–142.

    Article  CAS  Google Scholar 

  21. Czernik C, Lemmer J, Metze B, Koehne PS, Mueller C, Obladen M . B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res 2008; 64 (3): 286–290.

    Article  CAS  Google Scholar 

  22. Hsu JH, Yang SN, Chen HL, Tseng HI, Dai ZK, Wu JR . B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J Pediatr 2010; 157 (1): 79–84.

    Article  CAS  Google Scholar 

  23. El-Khuffash AF, Amoruso M, Culliton M, Molloy EJ . N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007; 92 (5): F421–F422.

    Article  Google Scholar 

  24. Jungbauer CG, Buchner S, Birner C, Resch M, Heinicke N, Debl K et al. N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction. Eur J Heart Fail 2010; 12 (4): 331–337.

    Article  CAS  Google Scholar 

  25. Cortes R, Portoles M, Salvador A, Bertomeu V, Garcia de Burgos F, Martinez-Dolz L et al. Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail 2006; 8 (6): 621–627.

    Article  CAS  Google Scholar 

  26. Kluckow M, Evans N . Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995; 127 (5): 774–779.

    Article  CAS  Google Scholar 

  27. Czernik C, Metze B, Muller C, Muller B, Buhrer C . Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity. Pediatrics 2011; 128 (3): e545–e549.

    PubMed  Google Scholar 

  28. Czernik C, Metze B, Muller C, Buhrer C . Urinary NT-proBNP and ductal closure in preterm infants. J Perinatol 2013; 33 (3): 212–217.

    Article  CAS  Google Scholar 

  29. Celik IH, Erdeve O, Demirel G, Canpolat FE, Dilmen U . Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants. Early Hum Dev 2013; 89 (3): 187–189.

    Article  CAS  Google Scholar 

  30. Linssen GC, Damman K, Hillege HL, Navis G, van Veldhuisen DJ, Voors AA . Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure. Circulation 2009; 120 (1): 35–41.

    Article  CAS  Google Scholar 

  31. Ng LL, Geeranavar S, Jennings SC, Loke I, O'Brien RJ . Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond) 2004; 106 (2): 129–133.

    Article  CAS  Google Scholar 

  32. Kroll MH, Srisawasdi P . The clearance of BNP modeled using the NT-proBNP-BNP relationship. Biosystems 2007; 88 (1-2): 147–155.

    Article  CAS  Google Scholar 

  33. Daniels LB, Maisel AS . Natriuretic peptides. J Am Coll Cardiol 2007; 50 (25): 2357–2368.

    Article  CAS  Google Scholar 

  34. Toyoshima K, Momma K, Imamura S, Nakanishi T . In vivo dilatation of the postnatal ductus arteriosus by atrial natriuretic peptide in the rat. Neonatology 2007; 92 (2): 139–144.

    Article  CAS  Google Scholar 

  35. Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M . Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review. Pediatrics 2015; 135 (2): e510–e525.

    Article  Google Scholar 

Download references

Acknowledgements

The project described was supported by the National Center for Advancing Translational Sciences, UL1TR000117, the Dean of the College of Medicine, University of Kentucky and Children’s Miracle Network (CMN) grant awarded to Kentucky Children’s Hospital. We thank our research nurses Vicky Whitehead and Deb Grider for their assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Hanna.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, S., Sithisarn, T., Bada, H. et al. Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus. J Perinatol 37, 1319–1324 (2017). https://doi.org/10.1038/jp.2017.139

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2017.139

This article is cited by

Search

Quick links